Correlation Between Purple Biotech and Dyadic International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Dyadic International, you can compare the effects of market volatilities on Purple Biotech and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Dyadic International.

Diversification Opportunities for Purple Biotech and Dyadic International

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Purple and Dyadic is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Purple Biotech i.e., Purple Biotech and Dyadic International go up and down completely randomly.

Pair Corralation between Purple Biotech and Dyadic International

Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Dyadic International. In addition to that, Purple Biotech is 1.36 times more volatile than Dyadic International. It trades about -0.18 of its total potential returns per unit of risk. Dyadic International is currently generating about 0.1 per unit of volatility. If you would invest  131.00  in Dyadic International on September 3, 2024 and sell it today you would earn a total of  40.00  from holding Dyadic International or generate 30.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  Dyadic International

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Dyadic International 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dyadic International are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Dyadic International demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Purple Biotech and Dyadic International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and Dyadic International

The main advantage of trading using opposite Purple Biotech and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.
The idea behind Purple Biotech and Dyadic International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Transaction History
View history of all your transactions and understand their impact on performance